ML
Moolec Science S.A.
MLEC · NASDAQ
$5.55 +0.54% (+$0.03)
1M -22.21%
Market Cap $4.52M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.01x
P/FCF N/A
P/B N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
13 /100
Weak FCF margin 9.02%
Op. margin 3.14%
Gross margin 34.17%
Quality
21 /100
Poor ROA 54.45%
Asset turnover 1.63x
ROIC 5.56%
Debt
0 /100
High Int. coverage -2.18x
Current ratio 0.13x
Net debt/EBITDA N/A
Stability
6 /100
Unstable EPS volatility 4,916.31%
Profitable years 0
Beta 0.26x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MLEC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alejandro Antalich
Employees
103
Headquarters
Grand Cayman